What factors do influence arterial hypertension control in Russia
https://doi.org/10.15829/1728-8800-2018-4-53-60
Abstract
In the work, the results presented, gathered in the multicenter study ESSE-RF, and characterizing factors associated with insufficient control of blood pressure (BP) in arterial hypertension (AH) patients.
Aim. Evaluation of the factors associated with insufficient BP control in Russian males and females age 25-64 y. o., with AH, by the ESSE-RF data.
Material and methods. Representative selections were assessed of 13 regions of Russia, males (n=5563) and females (n=9737) 25-64 y. o., investigated in 2012-2013 y. Systematic stratified multistage random selection was applied. Response about 80%. All participants were surveyed with a standard questionnaire (demography, anamnesis, wealth). Mean values were calculated (M±m), quintiles and ranges. Methods of analytical statistics were applied: dispersion-co variation, logistic regression, odds ratio.
Results. Two groups were revealed, with raised BP, that differ basically. Group one, those with BP higher than 140/90 mm Hg, not taking antihypertensive medication, and group two — those who take medications, but do not reach target BP. Group one consists of men almost 2 times more, with risk factors, but no cardiovascular diseases in anamnesis. Only the heart rate (HR) and alcohol overconsumption significantly positively correlate with the treatment absence in men — OR=1,49 (p<0,001) and OR=1,47 (p<0,0001), respectively, as in women — OR=1,41 (p<0,003) and OR=1,62 (p<0,0001). Group two is characterized by higher level of the risk factors, and complete model of logistic regression has revealed positive associations of high HR, general obesity, high triglycerides and glucose with ineffective treatment in males; in females — high HR, general obesity.
Conclusion. It is necessary to apply various approaches to increase the number of persons with controlled BP. Broad informing on healthy lifestyle, incl. target BP levels in those who do not visit physician office. Screening in AH is necessary, esp. for antihypertensive medication intake control.About the Authors
S. A. ShalnovaRussian Federation
Moscow
A. О. Konradi
Russian Federation
Saint-Petersburg
Yu. A. Balanova
Russian Federation
Moscow
A. D. Deev
Russian Federation
Moscow
A. E. Imaeva
Russian Federation
Moscow
G. A. Muromtseva
Russian Federation
Moscow
S. E. Evstifeeva
Russian Federation
Moscow
A. V. Kapustina
Russian Federation
Moscow
E. V. Shlyakhto
Russian Federation
Saint-Petersburg
S. A. Boytsov
Russian Federation
Moscow
О. М. Drapkina
Russian Federation
Moscow
References
1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990– 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380(9859):2224-60. doi:10.1016/S0140-6736(12)61766-8.A.
2. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressurerelated disease, 2001. The Lancet. 2008;371(9623):1513-8. doi:10.1016/S01406736(08)60655-8.
3. Wu CY, Hu HY, Chou YJ, et al. High blood pressure and all-cause and cardiovascular disease mortalities in community-dwelling older adults. Medicine. 2015;94(47):e2160. doi: 10.1097/MD.0000000000002160.
4. Forouzanfar MH, Liu P, Roth G A, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. JAMA. 2017;317(2):16582. doi:10.1001/jama.2016.19043.
5. Demographic book of Russia. Statistical book. Rosstat, М 2017; 263p. (In Russ.) Демографический ежегодник России. 2017: Стат. сб. Росстат, M 2017; 263 c. ISBN 978-5-89476447-4.
6. Grigoriev P, Meslé F, Shkolnikov VM, et al. The recent mortality decline in Russia: Beginning of the cardiovascular revolution? Population and Development review. 2014;40(1):107-29. doi:10.1111/j.1728-4457.2014.00652.x.
7. Vishnevsky A, Andreev E, Timonin S. Mortality from cardiovascular diseases and life expectancy in Russia. Demographic Review. 2016;3(1):6-34. (In Russ.) doi:10.17323/demreview.v3i1.1761.
8. Oganov RG, Timofeeva TN Koltunov IE, et al. Arterial hypertension epidemiology in Russia. The results of 2003-2010 Federal monitoring. Cardiovascular Therapy and Prevention. 2011;10(1):9-13. (In Russ.).
9. Shalnova SA, Deev AD, Vihireva OV, et al. The prevalence of hypertension in Russia. Awareness, treatment and control. Profilaktika zabolevanij i ukreplenie zdorov’ja. 2001;2:3-7. (In Russ.)
10. Boytsov SA, Balanova YuA, Shal’nova SA, et al. Arterial hypertension among individuals of 25–64 years old: prevalence, awareness, treatment and control. By the data from ECCD. Cardiovascular Therapy and Prevention. 2014;14(4):4-14. (In Russ.) doi:10.15829/1728-8800-2014-4-4-14
11. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. The Lancet. 2016;387(10022):957-67. doi:10.1016/S0140-6736(15)01225-8.
12. Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959-68. doi:10.1001/jama.2013.184182.
13. Devkota S, Dhungana RR, Pandey AR, et al. Barriers to treatment and control of hypertension among hypertensive participants: a community-based crosssectional mixed method study in municipalities of Kathmandu, Nepal. Frontiers in cardiovascular medicine. 2016;3:26. doi:10.3389/fcvm.2016.00026.
14. Kish L. Survey Sampling, New York: John Wiley and Sons, 1965.
15. Research organizing committee of the ESSE-RF project. Epidemiology of cardiovascular diseases in different regions of Russia (ESSE-RF). The rationale for and design of the study. J Profilakticheskaya meditsina. 2013;6:25-34. (In Russ.)
16. Jiang B, Hongmei LIU., Xiaojuan RU, et al. Hypertension detection, management, control and associated factors among residents accessing community health services in Beijing. Scientific reports. 2014;4:4845. doi:10.1038/srep04845.
17. Sengul S, Akpolat T, Erdem Y, et al. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens. 2016:34(6):1208. doi:10.1097/HJH.0000000000000901.
18. Llisterri-Caro JL, Rodriguez-Roca GC, Alonso-Moreno FJ, et al. Blood pressure control in hypertensive Spanish population attended in Primary Care setting. The PRESCAP 2010 study. Medicina clinica. 2012;139(15):653-61. doi:10.1016/j.medcli.2011.10.023.
19. Rodríguez Pérez MC, Cabrera de León A, Morales Torres RM, et al. Factors associated with knowledge and control of arterial hypertension in the Canary Islands. Revista Española de Cardiología (English Edition). 2012;65(3):234-40. doi:10.1016/J. REC.2011.09.023.
20. Khan NA, Hemmelgarn B, Herman RJ, et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2–therapy. Canadian Journal of Cardiology. 2009;25(5):287-98. doi:10.1016/S0828282X(09)70492-1.
21. Perret-Guillaume C, Joly L, Benetos A. Heart rate as a risk factor for cardiovascular disease. Progress in cardiovascular diseases. 2009;52(1):6-10. doi:10.1016/J.PCAD.2009.05.003.
22. Cordero A, Bertomeu-Martínez V, Mazón P. Factors Associated With Uncontrolled Hypertension in Patients With and Without Cardiovascular Disease. Rev. Española Cardiol. (English Ed. Elsevier Doyma). 2011;64(7):587-93. doi:10.1016/j.rec.2011.03.007.
23. Xu D, Chen W, Li X, et al. Factors associated with blood pressure control in hypertensive patients with coronary heart disease: evidence from the Chinese Cholesterol Education Program. PloS one. 2013;8(5):e63135. doi:10.1371/journal.pone.0063135.
24. Francischetti EA, Genelhu VA. Obesity–hypertension: an ongoing pandemic. International Journal of clinical practice. 2007;61(2):269-80. doi:10.1111/j.17421241.2006.01262.x
25. Balanova YA, Shalnova SA, Deev AD, et al. Obesity in Russian population — prevalence and association with the non-communicable diseases risk factors. Russian Journal of сardiology. 2018;(6):123-30. (In Russ.) doi: 10.15829/1560-4071-2018-6123-130.
26. Tian S, Dong GH, Wang D, et al. Factors associated with prevalence, awareness, treatment and control of hypertension in urban adults from 33 communities in China: the CHPSNE Study. Hypertension Research. 2011;34(10):1087. doi:10.1038/hr.2011.99.
27. Sakboonyarat B, Mungthin M. Prevalence and associated factors of uncontrolled hypertension among Thai patients with hypertension: A nationwide cross-sectional survey. Rev. Epidemiol. Sante Publique. Elsevier Masson. 2018;66:S310-1. doi:10.1016/J.RESPE.2018.05.194.
28. Journath G, Hellénius ML, Petersson U, et al. Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden. Eur J Cardiovasc Prev Rehabil. 2008;5(3):258-62. doi:10.1097/HJR.0b013e3282f37a45.
29. Shal’nova SA, Deev AD Oganov RG, et al. Pulse Rate and Cardiovascular Mortality of Men and Women in Russia. The Results of Epidemiological Studies. “KARDIOLOGIIA” 2005;45(10):45-50. (In Russ.)
30. Palatini P. Heart rate as predictor of outcome. Blood Press. Monit. 2008;13(3):167-8. doi:10.1097/MBP.0b013e3282fd1694.
31. Babiker FA, Elkhalifa LA, Moukhyer ME. Awareness of hypertension and factors associated with uncontrolled hypertension in Sudanese adults. Cardiovasc J Afr. 2013;24(6):208-12. doi:10.5830/CVJA-2013-035.
Review
For citations:
Shalnova S.A., Konradi A.О., Balanova Yu.A., Deev A.D., Imaeva A.E., Muromtseva G.A., Evstifeeva S.E., Kapustina A.V., Shlyakhto E.V., Boytsov S.A., Drapkina О.М. What factors do influence arterial hypertension control in Russia. Cardiovascular Therapy and Prevention. 2018;17(4):53-60. (In Russ.) https://doi.org/10.15829/1728-8800-2018-4-53-60